• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测对液体复苏难治的暴发性感染的实验室指标。

Laboratory markers predictive of fulminant infection refractory to fluid resuscitation.

作者信息

Ahmad Omar, Crawford Timothy N, Arora Vaneet, Maskey Mitu Karki

机构信息

Division of Infectious Diseases, University of Kentucky, 740 S. Limestone Street K512, Lexington, 40536, KY, USA.

Department of Population and Public Health Sciences, Wright State University, 3123 Research Boulevard, Dayton, 45420, OH, USA.

出版信息

Infect Prev Pract. 2021 Feb 15;3(2):100127. doi: 10.1016/j.infpip.2021.100127. eCollection 2021 Jun.

DOI:10.1016/j.infpip.2021.100127
PMID:34368744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8336175/
Abstract

BACKGROUND

Old age, leucocytosis, hypoalbuminemia, and elevated creatinine have been identified as risk factors for fulminant infection (CDI). High ATLAS scores have also been linked to fatal disease. The affiliated studies, however, involved patients prescribed metronidazole - a regimen no longer standard of care. The variables were thus reassessed in patients prescribed optimal therapy.

METHODS

Adults hospitalized with CDI at University of Kentucky Medical Center were retrospectively reviewed. Enrolled subjects were separated according to disease classification i.e. non-severe/severe versus fulminant CDI. Fulminant patients were further subdivided into hypotensive persons responsive to fluid resuscitation, and those with sequent shock, ileus, or megacolon. Following partition, the cohorts underwent correlation analysis.

FINDINGS

Forty-five subjects had non-severe/severe disease. Thirteen fulminant CDI patients responded to fluid resuscitation. Seventeen fulminant CDI patients developed shock, ileus, or megacolon. Median WBC counts, albumin values, and ATLAS scores varied among the cohorts. Although WBC counts were similar among the fulminant subsets, declining albumin values and increasing ATLAS scores mirrored disease worsening. Logistic regression revealed albumin values < 20 g/L (odds ratio [OR] 3.91) and ATLAS scores ≥ 6 (OR 5.03) to predict critical illness in hypotensive persons.

CONCLUSION

Median WBC counts, albumin values, and ATLAS scores differed in patients separated by CDI severity. A notable variance in albumin values and ATLAS scores between fluid responsive fulminant disease and critical illness was moreover seen. The finding suggests hypoalbuminemia and high ATLAS scores in hypotensive CDI patients may herald shock, ileus, or megacolon.

摘要

背景

老年、白细胞增多、低白蛋白血症和肌酐升高已被确定为暴发性感染(艰难梭菌感染)的危险因素。高ATLAS评分也与致命疾病有关。然而,相关研究涉及使用甲硝唑治疗的患者——这一治疗方案已不再是标准治疗方案。因此,对接受最佳治疗的患者的这些变量进行了重新评估。

方法

对肯塔基大学医学中心因艰难梭菌感染住院的成人患者进行回顾性研究。根据疾病分类,即非重度/重度与暴发性艰难梭菌感染,将入选患者分开。暴发性感染患者进一步细分为对液体复苏有反应的低血压患者,以及出现继发性休克、肠梗阻或巨结肠的患者。分组后,对这些队列进行相关性分析。

结果

45名患者患有非重度/重度疾病。13名暴发性艰难梭菌感染患者对液体复苏有反应。17名暴发性艰难梭菌感染患者出现休克、肠梗阻或巨结肠。各队列的白细胞计数中位数、白蛋白值和ATLAS评分各不相同。虽然暴发性感染亚组的白细胞计数相似,但白蛋白值下降和ATLAS评分升高反映了疾病的恶化。逻辑回归显示,白蛋白值<20 g/L(比值比[OR] 3.91)和ATLAS评分≥6(OR 5.03)可预测低血压患者的危重病。

结论

根据艰难梭菌感染严重程度分组的患者,其白细胞计数中位数、白蛋白值和ATLAS评分存在差异。此外,在对液体有反应的暴发性疾病和危重病之间,白蛋白值和ATLAS评分存在显著差异。这一发现表明,低血压艰难梭菌感染患者的低白蛋白血症和高ATLAS评分可能预示着休克、肠梗阻或巨结肠。

相似文献

1
Laboratory markers predictive of fulminant infection refractory to fluid resuscitation.预测对液体复苏难治的暴发性感染的实验室指标。
Infect Prev Pract. 2021 Feb 15;3(2):100127. doi: 10.1016/j.infpip.2021.100127. eCollection 2021 Jun.
2
Factors predictive of severe Clostridium difficile infection depend on the definition used.艰难梭菌严重感染的预测因素取决于所使用的定义。
Anaerobe. 2016 Feb;37:43-8. doi: 10.1016/j.anaerobe.2015.08.002. Epub 2015 Sep 1.
3
Surgical Infection Society Guidelines for Total Abdominal Colectomy versus Diverting Loop Ileostomy with Antegrade Intra-Colonic Lavage for the Surgical Management of Severe or Fulminant, Non-Perforated Colitis.外科感染学会关于全腹部结肠切除术与逆行经结肠腔内灌洗回肠造口术治疗严重或暴发性、非穿孔性结肠炎的手术治疗指南。
Surg Infect (Larchmt). 2022 Mar;23(2):97-104. doi: 10.1089/sur.2021.126. Epub 2021 Oct 7.
4
Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?静脉注射甲硝唑是否能改善艰难梭菌感染的疗效?
Clin Infect Dis. 2020 Dec 3;71(9):2414-2420. doi: 10.1093/cid/ciz1115.
5
Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.粪便微生物群移植可降低难治性严重或暴发性艰难梭菌感染患者的死亡率。
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2234-2243.e1. doi: 10.1016/j.cgh.2019.12.029. Epub 2020 Jan 8.
6
Hospitalized Older Patients with Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant.因感染住院且对传统抗生素治疗无效的老年患者可从粪便微生物群移植中获益。
Adv Geriatr Med Res. 2021;3(2). doi: 10.20900/agmr20210012. Epub 2021 Apr 30.
7
Clinical Usefulness of the "MN Criteria" - the Clostridioides difficile Infection Severity Scoring System - in the Japanese Setting.在日本环境下,“MN 标准”——艰难梭菌感染严重程度评分系统的临床实用性。
Intern Med. 2023 Jan 1;62(1):59-67. doi: 10.2169/internalmedicine.9540-22. Epub 2022 May 31.
8
Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.系统评价与荟萃分析:粪便微生物群移植治疗重度或暴发性艰难梭菌感染
Dig Dis Sci. 2022 Mar;67(3):978-988. doi: 10.1007/s10620-021-06908-4. Epub 2021 Mar 22.
9
Clinical factors associated with development of severe-complicated Clostridium difficile infection.与严重复杂性艰难梭菌感染发展相关的临床因素。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1466-71. doi: 10.1016/j.cgh.2013.04.050. Epub 2013 May 20.
10
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.实体器官移植受者中艰难梭菌感染的发生率和结局。
JAMA Netw Open. 2021 Dec 1;4(12):e2141089. doi: 10.1001/jamanetworkopen.2021.41089.

引用本文的文献

1
Discordance in Clinical Indicators With Sequential Fecal Microbiota Transplantation: A Case of Fulminant Infection.序贯粪菌移植临床指标的不一致性:一例暴发性感染病例
ACG Case Rep J. 2025 Jun 11;12(6):e01731. doi: 10.14309/crj.0000000000001731. eCollection 2025 Jun.

本文引用的文献

1
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南:成人和儿童艰难梭菌感染:美国传染病学会(IDSA)和美国医疗保健流行病学学会(SHEA) 2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.
2
Diagnosis and Treatment of Infection (CDI).艰难梭菌感染的诊断与治疗
Infect Dis Clin Pract (Baltim Md). 2016 Jan;24(1):3-10. doi: 10.1097/IPC.0000000000000350.
3
Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico.
应用ATLAS评分评估墨西哥教学医院艰难梭菌感染的严重程度。
Braz J Infect Dis. 2015 Jul-Aug;19(4):399-402. doi: 10.1016/j.bjid.2015.05.005. Epub 2015 Jun 25.
4
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
5
Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.艰难梭菌感染复发、并发症及死亡率的危险因素:一项系统评价
PLoS One. 2014 Jun 4;9(6):e98400. doi: 10.1371/journal.pone.0098400. eCollection 2014.
6
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.万古霉素、甲硝唑或托利美胺治疗艰难梭菌感染:两项多中心、随机、对照试验的结果。
Clin Infect Dis. 2014 Aug 1;59(3):345-54. doi: 10.1093/cid/ciu313. Epub 2014 May 5.
7
Surgical Management of Clostridium difficile Colitis.艰难梭菌性结肠炎的外科治疗
Clin Colon Rectal Surg. 2012 Dec;25(4):204-9. doi: 10.1055/s-0032-1329390.
8
Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection.一种简单、准确且稳健的预测艰难梭菌感染患者死亡风险的预测规则的推导和验证。
BMC Infect Dis. 2013 Jul 12;13:316. doi: 10.1186/1471-2334-13-316.
9
Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.一种简单的临床床边评分(ATLAS)用于预测艰难梭菌感染治疗反应的推导和验证。
BMC Infect Dis. 2013 Mar 25;13:148. doi: 10.1186/1471-2334-13-148.
10
Clostridium difficile ribotype does not predict severe infection.艰难梭菌核糖体分型不能预测严重感染。
Clin Infect Dis. 2012 Dec;55(12):1661-8. doi: 10.1093/cid/cis786. Epub 2012 Sep 12.